Drug Eluting Coronary Stents

Drug-eluting stents (DES) are specialized, mesh-like metal scaffolds coated with medication (e.g., everolimus, sirolimus) that are implanted in coronary arteries to prevent blockage caused by tissue regrowth (restenosis). They combine mechanical support for blood flow with drug delivery, significantly reducing the need for repeat procedures compared to bare-metal stents. About the Company Legal Status of Firm: Limited Company Number of Employees: 26 To 50 People Annual Turnover: 1.5 - 5 Cr company-description: We are one of the foremost Trader, Distributor and Wholesaler of ORS Electrolytes, Cardiac Hypertension Tablets, Gastro Medicines, Antibiotic Tablets, Nutrition Supplements, Respiratory Syrups, Pain Relief Medicine and much more. Our professionals work in close coordination to assure a high-quality assortment of products to the customers. We have recruited a team of professionals. In addition to this, to avoid disputes in the workplace, our professionals strive dedicatedly. Owing to our fare policies and the best quality products.Under the direction of our mentor, Mr. Sunit Ambadi , we are creating a long list of clients. Also, owing to his knowledge, commitment, skills, and ethical business strategies, we have been able to achieve a renowned position in the market.